サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654685

世界の静脈カニューレ市場-2025-2033年

Global IV Cannula Market - 2025-2033

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
世界の静脈カニューレ市場-2025-2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の静脈カニューレ市場は、2024年に4,590万米ドルに達し、2033年には7,470万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは5.6%で成長すると予測されています。

静脈カニューレとしても知られる静脈カニューレは、輸液や投薬、採血のために患者の静脈にアクセスするために使用される医療機器です。カニューレは、通常、針を通して静脈に挿入され、その後、カニューレを抜去し、継続的なアクセスを可能にします。カニューレは短期から中期的な使用を目的として設計されており、合併症を予防するために取り扱いには注意が必要です。

静脈カニューレ市場は、慢性疾患の増加、外科手術の増加、ヘルスケアインフラの進歩、在宅医療サービスの拡大など、さまざまな要因によって着実に成長しています。在宅医療や外来診療へのシフトにより、多くの患者が抗生物質や化学療法、水分補給療法などの治療を自宅で受けるようになったため、輸液カニューレの需要が増加しています。そのため、使いやすく、安全で信頼性の高い静脈アクセス・システムの需要が高まっています。例えば、米国臨床腫瘍学会（ASCO）の報告によると、米国では年間180万人以上の患者が新たにがんと診断され、これらの患者の多くが在宅での点滴化学療法を必要とするため、在宅ヘルスケアにおける静脈カニューレの需要が高まっています。

市場力学：

促進要因と抑制要因

手術件数の増加

外科手術件数の増加が静脈カニューレ市場の成長を大きく後押ししており、予測期間中も市場を牽引するとみられています。静脈カニューレの主な用途は、手術中の輸液、投薬、麻酔、輸血です。医療技術の進歩に伴い、世界的に待機手術と緊急手術の数が増加しています。これらの手術では、麻酔、輸液管理、薬剤投与などさまざまな目的で静脈内アクセスが必要となります。

例えば、米国国立衛生研究所（NIH）によると、世界では毎年3億1,000万件以上の大手術が行われており、このうち米国では約4,000万～5,000万件、欧州では約2,000万件の手術が行われています。このような手術件数の増加は、病院や手術センターにおける静脈カニューレの継続的な需要を浮き彫りにしています。

心臓手術、腫瘍外科手術、整形外科手術、形成外科手術、神経外科手術など、さまざまな外科手術の専門分野の増加により、安全システムや繊細な手技用の小さなゲージなどの高度な機能を備えたものを含め、特殊な静脈アクセス装置が必要とされています。例えば、国際美容形成外科学会（ISAPS）によると、外科手術の増加率は5.5％で、形成外科医による手術は1,580万件以上、外科手術以外の手術は1,910件以上です。過去4年間で、全体の増加率は40％です。このような形成外科手術の増加は、静脈カニューレの需要を押し上げています。

感染症や合併症のリスク

静脈カニューレの使用に伴う感染症や合併症のリスクは、静脈カニューレ市場の成長を妨げる大きな要因です。感染症やその他の合併症は、深刻な健康問題、入院期間の長期化、医療費の増加につながる可能性があり、患者の満足度を低下させ、静脈内治療の効果を損なう可能性があります。

静脈カニューレの使用に関する主な懸念事項の一つは、院内感染（HAI）、特に血流感染（BSI）や局所部位感染のリスクです。これらの感染症は一般的に、カニューレの不適切な挿入、不衛生、長時間の使用によって引き起こされ、静脈炎や敗血症などの合併症を引き起こします。

例えば、米国医療研究品質機構（Agency for Healthcare Research and Quality）によると、中心静脈ライン関連血流感染症（CLABSI）は最も一般的なHAIのひとつであり、米国では年間約28,000件の症例が報告されています。これらの感染症は静脈カテーテルの使用によって引き起こされる可能性があり、静脈カニューレの使用をためらわせ、市場の成長を鈍らせる一因となっています。

カニューレによる刺激で静脈に炎症が生じると、痛み、腫れ、時には感染症を引き起こす可能性があります。点滴液が血流に入る代わりに周囲の組織に漏れる浸潤も重大な合併症の一つです。ヘルスケア従事者は、特にリスクの高い環境では、静脈カニューレの挿入、操作、抜去の際に針刺し損傷の危険にさらされます。このような傷害は、HIV、B型肝炎、C型肝炎などの血液媒介病原体への曝露につながる可能性があります。

例えば、米国疾病予防管理センター（CDC）によると、米国の病院では年間約38万5,000件の針刺し損傷やその他のシャープス関連の損傷が発生しており、その多くが静脈カニューレに関連しています。このため、医療従事者と患者の安全に対する懸念が高まり、保護機能を内蔵したより安全な静脈カニューレの需要が高まっています。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別のスニペット
  • ゲージサイズ別スニペット
  • 素材別スニペット
  • 用途別スニペット
  • 最終用途別スニペット
  • 地域別スニペット

第3章 市場力学

  • 影響要因
    • 促進要因
      • 外科手術件数の増加
    • 抑制要因
      • 感染症や合併症のリスク
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学
  • キーオピニオンリーダー

第5章 静脈カニューレ市場、製品タイプ別

  • 周辺機器静脈カニューレ
  • 中央静脈カニューレ
  • ドレナージカニューレ

第6章 静脈カニューレ市場、ゲージサイズ別

  • 14G
  • 16G
  • 17G
  • 18G
  • 20G
  • 22G
  • 24G
  • 26G

第7章 静脈カニューレ市場、素材別

  • ポリウレタン
  • テフロン（ポリテトラフルオロエチレン（PTFE））
  • シリコーン
  • PVC（ポリ塩化ビニル）
  • その他

第8章 静脈カニューレ市場、用途別

  • 輸血
  • 医薬品管理
  • 外科手術
  • 診断手順
  • その他

第9章 静脈カニューレ市場、最終用途別

  • 病院
  • 専門クリニック
  • 在宅
  • その他

第10章 静脈カニューレ市場、地域別、市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場プレーヤー
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第12章 企業プロファイル

  • Becton, Dickinson and Company
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Nipro Corporation
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Medtronic plc
  • Cruzine
  • MRK Healthcare Pvt. Ltd.
  • Bio Med Healthcare Products Pvt Ltd
  • AdvaCare Pharma
  • iLife Medical Devices Pvt Ltd
  • Neotec Medical

第13章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第14章 付録

目次
Product Code: MDP9129

The global IV cannula market reached US$ 45.9 million in 2024 and is expected to reach US$ 74.7 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

An IV cannula, also known as an intravenous cannula, is a medical device used to provide access to a patient's vein for the purpose of administering fluids, medications or drawing blood. It is a small, flexible tube typically inserted into the vein through a needle, which is then removed, leaving the cannula in place to allow ongoing access. It is designed for short- to medium-term use and must be handled with care to prevent complications.

The IV cannula market is growing steadily due to various factors such as the increasing prevalence of chronic diseases, rising surgical procedures, advancements in healthcare infrastructure and expanding home healthcare services. The shift towards home healthcare and outpatient care has increased the demand for IV cannulas, as many patients now receive treatments like antibiotics, chemotherapy, or hydration therapy at home. This has led to a rise in demand for easy-to-use, safe, and reliable IV access systems. For instance, the American Society of Clinical Oncology (ASCO) reports that over 1.8 million new cancer cases are diagnosed annually in the U.S., and many of these patients will require home-based IV chemotherapy infusions, contributing to the rising demand for IV cannulas in home healthcare.

Market Dynamics: Drivers & Restraints

Rising number of surgical procedures

The rising number of surgical procedures is significantly driving the growth of the IV cannula market and is expected to drive the market over the forecast period. Their primary use is for providing fluid administration, medication delivery, anesthesia, and blood transfusion during surgeries. With advancements in medical technology, the global number of both elective and emergency surgeries has increased. These procedures require IV access for various purposes such as anesthesia, fluid management, and medication administration.

For instance, according to the National Institute of Health (NIH), globally, over 310 million major surgeries are performed every year, in this, around 40 to 50 million surgeries are performed in USA and 20 million surgeries are performed in Europe. This rising number of surgical procedures highlights a continuous demand for IV cannulas in hospitals and surgical centers.

The rise in the variety of surgical specialties such as cardiac surgeries, oncological surgeries, orthopedic surgeries, plastic surgeries and neurosurgeries necessitates specialized IV access devices, including those with advanced features like safety systems or small gauges for delicate procedures. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons and 19.1 non-surgical procedures. Over the last four years, the overall increase is 40%. This rising plastic surgeries boosts the demand for IV cannulas.

Risk of infections and complications

The risk of infections and complications associated with the use of IV cannulas is a significant factor hampering the growth of the IV cannula market. Infections and other complications can lead to severe health issues, prolonged hospital stays, and increased medical costs, which can reduce patient satisfaction and undermine the effectiveness of IV therapies.

One of the major concerns with IV cannula use is the risk of hospital-acquired infections (HAIs), particularly bloodstream infections (BSIs) and local site infections. These infections are typically caused by improper insertion, lack of hygiene or prolonged use of the cannula, leading to complications such as phlebitis or sepsis.

For instance, according to Agency for Healthcare Research and Quality, central-line-associated bloodstream infections (CLABSIs) are among the most common types of HAIs, with approximately 28,000 cases reported annually in the U.S. These infections can result from the use of intravenous catheters, contributing to the hesitancy in using IV cannulas and slowing market growth.

Inflammation of the vein due to irritation caused by the cannula can lead to pain, swelling, and sometimes infection. Infiltration, where the IV fluid leaks into the surrounding tissue instead of entering the bloodstream, is another significant complication. Healthcare workers are at risk of needle-stick injuries when inserting, manipulating, or removing IV cannulas, especially in high-risk environments. These injuries can lead to exposure to bloodborne pathogens such as HIV, Hepatitis B and Hepatitis C.

For instance, according to Centers for Disease Control and Prevention (CDC), approximately 385,000 needle-stick injuries and other sharps-related injuries occur annually in U.S. hospitals, many involving IV cannulas. This raises concerns about the safety of healthcare workers and patients, influencing the demand for safer IV cannulas with built-in protective features.

Segment Analysis

The global IV cannula market is segmented based on product type, gauge size, material, application, end-user and region.

Product Type:

The peripheral IV cannula segment is expected to dominate the IV cannula market share

Peripheral IV cannulas are primarily used for fluid infusion, medication administration, blood transfusions and anesthesia in patients requiring short-term intravenous access. They are particularly common in emergency departments, pediatric care and surgical units. For instance, the American Society of Anesthesiologists (ASA) reports that over 40 to 50 million surgeries are performed annually in the U.S., with peripheral IV cannulas being used in a majority of these procedures for anesthesia and fluid administration.

Peripheral IV cannulas are typically used for short-term intravenous access (generally up to 72 hours) and can be quickly inserted into peripheral veins, such as those in the arm, hand, or forearm. The ease of insertion makes them ideal for emergency situations and routine clinical procedures. According to a study in the Journal of Infusion Nursing, peripheral IV cannulas are used in approximately 75-80% of all hospital admissions for intravenous therapy, largely due to their simplicity, speed, and effectiveness.

Geographical Analysis

North America is expected to hold a significant position in the IV cannula market share

The high prevalence of surgeries in North America, driven by the aging population and the widespread use of medical technologies, directly boosts the demand for IV cannulas. These procedures require intravenous access for medications, fluids, and anesthesia. The National Institute of Health (NIH) reports that more than 40 million surgeries are performed annually in the U.S., most of which involve the use of IV cannulas for intravenous access during procedures.

In North America, there is a growing focus on patient safety and the prevention of healthcare-associated infections (HAIs), which drives demand for safer IV cannulas. This includes the adoption of safety features in IV cannulas, such as shielded needles, antimicrobial coatings and advanced insertion technology. The demand for safer IV cannulas in North America is accelerating due to an increased focus on preventing needle-stick injuries and hospital-acquired infections (HAIs).

Asia-Pacific is growing at the fastest pace in the IV cannula market

Several countries in the APAC region, such as India, China, and Southeast Asia, are experiencing rapid growth in their healthcare infrastructure. Governments and private sectors are investing in medical facilities, hospitals, and clinics to meet the needs of a growing and aging population, which directly contributes to the demand for medical devices, including IV cannulas.

For instance, the Indian government has introduced initiatives like the Ayushman Bharat program, which aims to provide healthcare access to over 500 million people. This program has led to increased healthcare investments, directly boosting demand for medical devices such as IV cannulas.

The rise in medical tourism in countries such as India, Thailand, and Singapore contributing to the demand for advanced medical devices like IV cannulas. Medical tourists often seek affordable and high-quality medical treatments, including surgeries, which require intravenous therapies, driving the market for IV cannulas. For instance, India is one of the world's top destinations for medical tourism, with over 5 million medical tourists visiting annually for treatments like cardiac surgery, orthopedic surgeries, and cosmetic surgeries, all of which require intravenous access.

Competitive Landscape

The major global players in the IV cannula market include Becton, Dickinson and Company, Nipro Corporation, Romsons Scientific & Surgical Pvt. Ltd., Medtronic plc, Cruzine, MRK Healthcare Pvt. Ltd., Bio Med Healthcare Products Pvt Ltd, AdvaCare Pharma, iLife Medical Devices Pvt Ltd, Neotec Medical and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global IV cannula market report delivers a detailed analysis with 78 key tables, more than 83 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Gauge Size
  • 2.5. Snippet by Material
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Number of Surgical Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Infections and Complications
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. IV Cannula Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Peripheral IV Cannula*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Central IV Cannula
  • 5.4. Draining Cannulas

6. IV Cannula Market, By Gauge Size

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 6.1.2. Market Attractiveness Index, By Gauge Size
  • 6.2. 14G*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 16G
  • 6.4. 17G
  • 6.5. 18G
  • 6.6. 20G
  • 6.7. 22G
  • 6.8. 24G
  • 6.9. 26G

7. IV Cannula Market, By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. Polyurethane*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Teflon (Polytetrafluoroethylene (PTFE))
  • 7.4. Silicone
  • 7.5. PVC (Polyvinyl Chloride)
  • 7.6. Others

8. IV Cannula Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Blood Transfusion*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Drug Administration
  • 8.4. Surgical Procedures
  • 8.5. Diagnostic Procedures
  • 8.6. Others

9. IV Cannula Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Homecare Settings
  • 9.5. Others

10. IV Cannula Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Becton, Dickinson and Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Nipro Corporation
  • 12.3. Romsons Scientific & Surgical Pvt. Ltd.
  • 12.4. Medtronic plc
  • 12.5. Cruzine
  • 12.6. MRK Healthcare Pvt. Ltd.
  • 12.7. Bio Med Healthcare Products Pvt Ltd
  • 12.8. AdvaCare Pharma
  • 12.9. iLife Medical Devices Pvt Ltd
  • 12.10. Neotec Medical

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us